UNIQURE N.V. EO -,05/ NL0010696654 /
| 10/4/2023 8:14:31 AM | Chg. +0.1200 | Volume | Bid11:47:10 AM | Ask11:47:10 AM | High | Low |
|---|---|---|---|---|---|---|
| 5.8200EUR | +2.11% | 0 Turnover: 0.0000 |
5.8300Bid Size: 700 | 6.2300Ask Size: 700 | 5.8200 | 5.8200 |
GlobeNewswire
3/21/2022
uniQure Announces Completion of Patient Enrollment in the First Two Cohorts of its Phase I/II Clinic...
GlobeNewswire
3/2/2022
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
GlobeNewswire
2/25/2022
uniQure Announces 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire
2/7/2022
uniQure Announces Dosing of First Patients in European Open-Label Clinical Trial of AMT-130 Gene The...
GlobeNewswire
12/16/2021
uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene The...
GlobeNewswire
12/9/2021
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene D...
GlobeNewswire
11/10/2021
Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update
GlobeNewswire
11/2/2021
uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Cli...
GlobeNewswire
10/25/2021
uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire
10/21/2021
uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
GlobeNewswire
10/19/2021
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Thera...
GlobeNewswire
9/15/2021
Vaccinex CEO, Dr. Maurice Zauderer, Presented New and Promising Phase 2 SIGNAL Trial Data in a Plena...
GlobeNewswire
9/7/2021
uniQure to Participate in Multiple Upcoming Industry Conferences in September
GlobeNewswire
8/30/2021
uniQure Announces Completion of Additional Patient Procedures Following Positive Recommendation from...
GlobeNewswire
8/16/2021
Freeline Appoints Michael J. Parini as Chief Executive Officer and Reports Second Quarter 2021 Finan...
GlobeNewswire
8/13/2021
Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Q...
GlobeNewswire
7/26/2021
uniQure Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire
7/2/2021
uniQure Announces Presentations at Upcoming International Society on Thrombosis and Haemostasis (IS...
GlobeNewswire
6/22/2021
uniQure Announces Positive 52-Week Clinical Data from HOPE-B Pivotal Trial of Etranacogene Dezaparvo...
GlobeNewswire
6/22/2021
uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe...
GlobeNewswire
6/16/2021
uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of ...
GlobeNewswire
6/2/2021
UPDATE -- uniQure to Participate in Multiple Upcoming Industry Conferences in June